awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37164063-05726EBD-34C0-443E-89CE-624E7C40663C
Q37164063-05726EBD-34C0-443E-89CE-624E7C40663C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37164063-05726EBD-34C0-443E-89CE-624E7C40663C
Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.
P2860
Q37164063-05726EBD-34C0-443E-89CE-624E7C40663C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37164063-05726EBD-34C0-443E-89CE-624E7C40663C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b7217df33c337a7c9a07e8bdc92f1e42eeb7c8b
P2860
A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome.